Apyx Medical Corp Marketable Securities (Current)
Apyx Medical Corp (APYX) had Marketable Securities (Current) of $39.66 million as of 2020-12-31, per its 10-K filed 2021-03-31.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Short-Term Investments
us-gaap:MarketableSecuritiesCurrent · last filed 2021-03-31
- 2020-12-31: Marketable Securities, Current $39.66M.
- 2019-12-31: Marketable Securities, Current $56.58M.
- 2019-09-30: Marketable Securities, Current $61.00M.
| Period end | Marketable Securities, Current |
|---|---|
| 2020-12-31 | $39.66M 10-K · filed 2021-03-31 |
| 2019-12-31 | $56.58M 10-K · filed 2021-03-31 |
| 2019-09-30 | $61.00M 10-Q · filed 2019-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| KORU Medical Systems, Inc. (KRMD) | United States | $0.151B | -106.78 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| Lucid Diagnostics Inc. (LUCD) | United States | $0.170B | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 |